Psychemedics Stock Performance
| PMD Stock | USD 2.67 0.06 2.30% |
On a scale of 0 to 100, Psychemedics holds a performance score of 5. The company holds a Beta of -0.35, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Psychemedics are expected to decrease at a much lower rate. During the bear market, Psychemedics is likely to outperform the market. Please check Psychemedics' kurtosis, and the relationship between the downside variance and day median price , to make a quick decision on whether Psychemedics' historical price patterns will revert.
Risk-Adjusted Performance
5 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Psychemedics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak primary indicators, Psychemedics exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
Five Day Return 42.02 | Year To Date Return (21.24) | Ten Year Return (81.96) | All Time Return (78.84) |
| Begin Period Cash Flow | 4.8 M |
Psychemedics |
Psychemedics Relative Risk vs. Return Landscape
If you would invest 232.00 in Psychemedics on October 1, 2024 and sell it today you would earn a total of 35.00 from holding Psychemedics or generate 15.09% return on investment over 90 days. Psychemedics is generating 0.4209% of daily returns assuming volatility of 5.93% on return distribution over 90 days investment horizon. In other words, 52% of stocks are less volatile than Psychemedics, and above 92% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Psychemedics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Psychemedics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Psychemedics, and traders can use it to determine the average amount a Psychemedics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.071
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | PMD | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.93 actual daily | 52 52% of assets are less volatile |
Expected Return
| 0.42 actual daily | 8 92% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Psychemedics is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Psychemedics by adding it to a well-diversified portfolio.
Psychemedics Fundamentals Growth
Psychemedics Stock prices reflect investors' perceptions of the future prospects and financial health of Psychemedics, and Psychemedics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Psychemedics Stock performance.
| Return On Equity | -0.61 | ||||
| Return On Asset | -0.16 | ||||
| Profit Margin | (0.22) % | ||||
| Operating Margin | (0.19) % | ||||
| Current Valuation | 14.22 M | ||||
| Shares Outstanding | 5.89 M | ||||
| Price To Earning | 92.08 X | ||||
| Price To Book | 2.58 X | ||||
| Price To Sales | 0.76 X | ||||
| Revenue | 22.1 M | ||||
| EBITDA | (251 K) | ||||
| Cash And Equivalents | 1.79 M | ||||
| Cash Per Share | 0.32 X | ||||
| Total Debt | 2.3 M | ||||
| Debt To Equity | 0.36 % | ||||
| Book Value Per Share | 1.15 X | ||||
| Cash Flow From Operations | (1.48 M) | ||||
| Earnings Per Share | (0.51) X | ||||
| Total Asset | 12.33 M | ||||
| Retained Earnings | (16.77 M) | ||||
| Current Asset | 8.46 M | ||||
| Current Liabilities | 3.56 M | ||||
About Psychemedics Performance
By analyzing Psychemedics' fundamental ratios, stakeholders can gain valuable insights into Psychemedics' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Psychemedics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Psychemedics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. Psychemedics Corporation was incorporated in 1986 and is headquartered in Acton, Massachusetts. Psychemedics operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 1 people.Things to note about Psychemedics performance evaluation
Checking the ongoing alerts about Psychemedics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Psychemedics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Psychemedics is not yet fully synchronised with the market data | |
| Psychemedics had very high historical volatility over the last 90 days | |
| The company reported the last year's revenue of 22.1 M. Reported Net Loss for the year was (4.15 M) with profit before taxes, overhead, and interest of 9.29 M. | |
| Psychemedics has about 1.79 M in cash with (1.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.32. | |
| Roughly 23.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from MacroaxisInsider: Acquisition by Powell Anderson Capital Partners Llc of 4518 shares of Psychemedics at 2.71 subject to Rule 16b-3 |
- Analyzing Psychemedics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Psychemedics' stock is overvalued or undervalued compared to its peers.
- Examining Psychemedics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Psychemedics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Psychemedics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Psychemedics' stock. These opinions can provide insight into Psychemedics' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Psychemedics Stock analysis
When running Psychemedics' price analysis, check to measure Psychemedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Psychemedics is operating at the current time. Most of Psychemedics' value examination focuses on studying past and present price action to predict the probability of Psychemedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Psychemedics' price. Additionally, you may evaluate how the addition of Psychemedics to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |